Year archive

Optimi Health Corp. — 2026 filings

All 23 regulatory filings released by Optimi Health Corp. (OPTI) in 2026, sourced directly from the official regulator.

23 Filings

2026 Period

2026 filings (23)

Filing	Released	Lang
Notice.pdf Regulatory Filings	2026-05-22	English
Optimi Health gibt Preisfestsetzung fur uberzeichnetes offentliches Angebot in Hohe von 15 Mio. US-$ und Nasdaq-Uplisting bekannt Capital/Financing Update	2026-05-20	German
Offering document - English.pdf Share Issue/Capital Change	2026-04-25	English
Offering document - English.pdf Capital/Financing Update	2026-04-25	English
News release - English.pdf Capital/Financing Update	2026-04-23	English
News release - English.pdf Regulatory Filings	2026-04-20	English
News release - English.pdf Regulatory Filings	2026-04-20	English
News release - English.pdf Regulatory Filings	2026-04-20	English
Optimi Health startet Ibogaine-Initiative, da US-Executive Order einen Weg fur psychedelische Arzneimittelprodukte signalisiert Regulatory Filings	2026-04-20	German
Statement of executive compensation (form 51-102F6V) - English.pdf Remuneration Information	2026-04-08	English
Optimi Health berichtet uber den fruhen klinischen Einsatz naturlicher Psilocybin-Kapseln zur Behandlung therapieresistenter Depressionen in Australien Regulatory Filings	2026-02-26	German
Optimi Health schliet Psilocybin-Export nach Australien zur Behandlung therapieresistenter Depression ab Regulatory Filings	2026-02-19	German
News release - English.pdf Capital/Financing Update	2026-02-17	English
Optimi Health meldet Beginn der ersten MDMA-gestutzten Behandlungen im Jahr 2026 in einem erweiterten Netzwerk australischer Kliniken Regulatory Filings	2026-02-16	German
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings FY 2025	2026-01-29	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Audit Report / Information FY 2025	2026-01-29	English
Annual MD&A - English.pdf Management Reports	2026-01-29	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2026-01-29	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2026-01-29	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2025	2026-01-29	English
News release - English.pdf Regulatory Filings	2026-01-26	English
News release - English.pdf Share Issue/Capital Change	2026-01-16	English
News release - English.pdf Regulatory Filings	2026-01-14	English